Beta-adrenoceptor blockers
Important safety information (for all beta-blockers)
The CSM has advised that all betablockers including those with cardioselectivity should not be used in patients with asthma or obstructive airways disease unless no other treatment is available. In such cases the risk of inducing bronchospasm should be appreciated and appropriate precautions taken.
| Pack |
|---|
| 5 ml |
| Pack |
|---|
| 5 ml |
| Pack |
|---|
| 3 ml |
| Pack |
|---|
| 3 ml |
Preservative free eye gel
| Pack |
|---|
| 30 unit dose (3 x 10 x 0.4g unit doses) |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary